MyFinsight
Home
Blog
About
Contact
Download
Download image
Prepaid expenses and
other current assets
$22,208K
Other receivables
$35,480K
Inventory
$56,341K
Accounts receivable, net
$47,013K
Marketable securities
$49,443K
Cash and cash
equivalents
$473,966K
Other noncurrent
assets
$2,913K
Intangible assets, net
$62,329K
Goodwill
$4,511K
Operating lease
right-of-use assets
$60,450K
Property and equipment,
net
$226,711K
Total current assets
$684,451K
Total assets
$1,041,365K
Total liabilities and
stockholders equity
$1,041,365K
Total stockholders
equity
$796,326K
Total liabilities
$245,039K
Accumulated deficit
-$1,510,591K
Accumulated other
comprehensive income (loss)
$225K
Additional paid-in capital
$2,306,690K
Operating lease
liabilities, noncurrent
$73,376K
Other noncurrent
liabilities
$6,471K
Deferred revenue,
noncurrent
$10,501K
Contingent consideration,
noncurrent
$1,237K
Total current
liabilities
$153,454K
Common stock, 0.00001
par value...
$2K
Operating lease
liabilities
$10,985K
Accrued expenses and
other current...
$39,971K
Accrued compensation
and related...
$42,500K
Contingent consideration,
current
$23,363K
Deferred revenue
$23,902K
Accounts payable
$12,733K
Back
Back
Balance Sheet
source: myfinsight.com
10x Genomics, Inc. (TXG)
10x Genomics, Inc. (TXG)